Prevalence And Risk Factors Associated With Human Papillomavirus Infection Among Women In Nonthaburi Province
Article Sidebar
Main Article Content
Abstract
Background: Cervical cancer, primarily caused by the Human papillomavirus (HPV) is the fourth most prevalent cancer in women. Previous studies found varying prevalence of HPV infection, and the risk factors have yet to be determined. Furthermore, the prevalence of HPV infection in Nonthaburi province has never been examined.
Objective: The purpose of this study was to examine the prevalence and risk factors related with HPV infection among women in Nonthaburi Province.
Methods: The study design was a retrospective analytic study. Data was collected from the National Cancer Institute (NCI) database's HPV screening system. The study included 12,118 Thai women aged 15-60 years who had cervical cancer screening by HPV DNA test in Nonthaburi province between November 2021 and August 2023. Exclusion criteria were the absence of positive/negative HPV results and inadequate data to analyse. General information, HPV DNA test results, and liquid-based cytology (LBC) test results were obtained. The descriptive statistics and logistic regression were used in the statistical analysis.
Results: The prevalence of HPV infection among women in Nonthaburi was 7.93%. HPV Type non 16, 18 infections had a prevalence of 5.72%, HPV Type 16 had 1.59% and HPV Type 18 had 0.62%. Age and hormone use were among the parameters associated with HPV infection.
Conclusion: The findings on the prevalence of HPV infection in Nonthaburi Province, as well as risk factors for HPV infection, can be used as a guideline for screening patients. Furthermore, promoting cervical screening, immunization for young women, and avoiding the use of hormonal contraception will help reduce the risk of cervical cancer in the future
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209-49.
Cohen PA, Jhingran A, Oaknin A, Denny L. Cervical cancer. The Lancet. 2019;393(10167):169-82.
Forman D, de Martel C, Lacey CJ, Soerjomataram I, Lortet-Tieulent J, Bruni L, et al. Global burden of human papillomavirus and related diseases. Vaccine. 2012;30 Suppl 5:F12-23.
Kombe Kombe AJ, Li B, Zahid A, Mengist HM, Bounda GA, Zhou Y, et al. Epidemiology and Burden of Human Papillomavirus and Related Diseases, Molecular Pathogenesis, and Vaccine Evaluation. Frontiers in public health. 2020;8:552028.
Monteiro JC, Tsutsumi MY, de Carvalho DO, da Silva Costa EDC, Feitosa RNM, Laurentino RV, et al. Prevalence, Diversity, and Risk Factors for Cervical HPV Infection in Women Screened for Cervical Cancer in Belém, Pará, Northern Brazil. Pathogens (Basel, Switzerland). 2022;11(9).
Swangvaree SS, Kongkaew P, Rugsuj P, Saruk O. Prevalence of high-risk human papillomavirus infection and cytologic results in Thailand. Asian Pac J Cancer Prev. 2010;11(6):1465-8.
Phetphichai S, Klykleung N, Pota A, Bunkhong A, Kanyabun P. The Prevalence of High-risk HPV Type among Thai Women in Phichit, Uthai Thani,Chainat, and Kamphaeng Phet Provinces. Bull Dept Med Sci. 2021;63(4):766-81.
Malasan T. Prevalence and genotypic distribution of human papillomavirus infection among women in Kamalasai District Kalasin Province. hej. 2022;7(4):144-22.
Yang D, Zhang J, Cui X, Ma J, Wang C, Piao H. Risk factors associated with human papillomavirus infection, cervical cancer, and precancerous lesions in large-scale population screening. Frontiers in Microbiology. 2022;13:914516.
Boonthum N, Suthutvoravut S. Prevalence, types, and factors of HPV infection among women with abnormal cervical cytology screening at Ramathibodi hospital. Rama Med J. 2021;44(3):12-9.
Roman C, Andrade D, Hernández Y, Salazar ZK, Espinosa L, Campoverde E, Guallaizaca L, Merchán M, Sarmiento M, Brenner J. Biological, demographic, and health factors associated with HPV infection in Ecuadorian women. Frontiers in Public Health.
;11:1158270.
Boonthum N, Suthutvoravut S. Prevalence, Types, and Factors of HPV Infection Among Women With Abnormal Cervical Cytology Screening at Ramathibodi Hospital. Ramathibodi Medical Journal. 2021;44(3):12-9.
Swiderska-Kiec J, Czajkowski K, Zareba-Szczudlik J, Kacperczyk-Bartnik J, Bartnik P, Romejko-Wolniewicz E. Comparison of HPV Testing and Colposcopy in Detecting Cervical Dysplasia in Patients With Cytological Abnormalities. In vivo (Athens, Greece). 2020; 34(3):1307-15.
The Royal Thai College of Obstetricians and Gynaecologists. Cervical Cancer Screening. Bangkok: The Royal Thai College of Obstetricians and Gynaecologists; 2021.
Phoolcharoen N, Kantathavorn N, Sricharunrat T, Saeloo S, Krongthong W. A population-based study of cervical cytology findings and human papillomavirus infection in a suburban area of Thailand. Gynecol Oncol Rep. 2017;21:73-7.
Tangjitgamol S, Kantathavorn N, Kittisiam T, Chaowawanit W, Phoolcharoen N, Manusirivithaya S, et al. Prevalence and associated factors of abnormal cervical cytology and highRisk HPV DNA among Bangkok metropolitan women. Asian Pac J Cancer Prev. 2016;17(7):3147-53.
Chansaenroj J, Lurchachaiwong W, Termrungruanglert W, Tresukosol D, Niruthisard S, Trivijitsilp P, et al. Prevalence and genotypes of human papillomavirus among Thai women. Asian Pac J Cancer Prev. 2010;11(1):117-22.
Phansri T, Boonmark K, Ngamkham J. Retrospective study of human papilloma virus infection in Thailand: A Systematic Review. Thai Cancer J. 2022;42(1). 10-29
Laohutanon P., Chaiwerawattana A., Imsamran W. Screening guidelines Diagnose and Treatment of Cervical cancer. Bangkok: National Cancer Institute; 2018.
Smith JS, Melendy A, Rana RK, Pimenta JM. Age-specific prevalence of infection with human papillomavirus in females: a global review. J Adolesc Health. 2008;43(4 Suppl): S5-25, S.e1-41.
Roset Bahmanyar E, Paavonen J, Naud P, Salmerón J, Chow S-N, Apter D, et al. Prevalence and risk factors for cervical HPV infection and abnormalities in young adult women at enrolment in the multinational PATRICIA trial. Gynecol Oncol. 2012;127(3):440-50.
